Teva (TEVA) Pharmaceuticals announced the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to eligible patients in the United States free of charge ...

Teva Pharmaceutical stock has rebounded from lows, driven by debt reduction, halted price deflation in generics, and new product launches, making it a strong buy. Teva's innovative branded drugs ...

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) announced that it will divest Teva-Takeda, its business venture in Japan, to JKI Co., Ltd. The divestment, which includes generics and legacy ...

Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. ("J-Will”), through which JKI will ...

Then: In an article published in the October 2013 issue of Life Science Leader, former executive editor Wayne Koberstein spoke with Teva’s then CEO Jeremy Levin about the company’s strategy to bridge ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...